All In MedTech

Device Trial Radar · NCT05814211

Clinical Trial of New Intermittent Single-use Catheter

A Randomized, Open-labelled, Crossover Study Confirming Performance of a New Single-use Compact Intermittent Catheter in a Population of Adult Female Intermittent Catheter Users

Last checked: Nov 20, 2026Latest source record: Feb 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

82

Actual

Start

Aug 4, 2023

Primary completion

Nov 29, 2023

Study completion Nov 29, 2023

Sponsor

Lead sponsor
Coloplast A/SNot on our public-company list
Sponsor type
Industry
First posted
Apr 14, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A multi-centre, open-labelled, randomised, crossover design. The total study duration for the individual subject will be approximately 4 weeks, consisting of four site visits and two 2-week test periods at home. Visits 0 and 1 can be performed on the same day. For visit 2 and 3, 2 catheterisations will be performed in a hospital setting (one HCP catheterisation and one self-catheterisation) for bladder emptying and user experience assessments. Visit 1 and 2 are followed by a home-use test period, followed by visit 3 which terminates the study.

Conditions

  • Urinary Incontinence

Interventions

  • Investigational device - newly developed intermittent catheterDevice

    Ready-to-use, sterile, hydrophilic coated intermittent female compact catheter (sizes CH12 and CH14) for urinary drainage. The investigational device is for single use.

  • Comparator device #1 - SpeediCath EveDevice

    During comparator study period, subjects will only receive one of the comparator products. Randomization will decide which one. Ready-to-use, sterile, hydrophilic coated intermittent female compact catheter (sizes CH12 and CH14) for urinary drainage. The comparator device is for single use.

  • Comparator device #2 - SpeediCath Compact Plus FemaleDevice

    During comparator study period, subjects will only receive one of the comparator products. Randomization will decide which one. Ready-to-use, sterile, hydrophilic coated intermittent female compact catheter (sizes CH12 and CH14) for urinary drainage. The comparator device is for single use.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Residual Volume at 1st Flow-stop (Catheterisation Performed by HCP)Time frame: Tested at site visit after 14 days of device home use.

Locations

11 sites in 3 countries. Site status is shown where the registry gives one.

  • Odense Universitetshospital

    Odense, Denmark

  • Sanos Clinic Vejle

    Vejle, Denmark

  • Rigshopsitalet

    Copenhagen, København Ø, Denmark

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.